Literature DB >> 22135282

Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis.

Eoin P Judge1, Aurelie Fabre, Huzaifa I Adamali, Jim J Egan.   

Abstract

The aim of this study was to evaluate the risk factors for and outcomes of acute exacerbations in patients with advanced idiopathic pulmonary fibrosis (IPF), and to examine the relationship between disease severity and neovascularisation in explanted IPF lung tissue. 55 IPF patients assessed for lung transplantation were divided into acute (n=27) and non-acute exacerbation (n=28) groups. Haemodynamic data was collected at baseline, at the time of acute exacerbation and at lung transplantation. Histological analysis and CD31 immunostaining to quantify microvessel density (MVD) was performed on the explanted lung tissue of 13 transplanted patients. Acute exacerbations were associated with increased mortality (p=0.0015). Pulmonary hypertension (PH) at baseline and acute exacerbations were associated with poor survival (p<0.01). PH at baseline was associated with a significant risk of acute exacerbations (HR 2.217, p=0.041). Neovascularisation (MVD) was significantly increased in areas of cellular fibrosis and significantly decreased in areas of honeycombing. There was a significant inverse correlation between mean pulmonary artery pressure and MVD in areas of honeycombing. Acute exacerbations were associated with significantly increased mortality in patients with advanced IPF. PH was associated with the subsequent development of an acute exacerbation and with poor survival. Neovascularisation was significantly decreased in areas of honeycombing, and was significantly inversely correlated with mean pulmonary arterial pressure in areas of honeycombing.

Entities:  

Mesh:

Year:  2011        PMID: 22135282     DOI: 10.1183/09031936.00115511

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  36 in total

Review 1.  Management of interstitial lung disease associated with connective tissue disease.

Authors:  Stephen C Mathai; Sonye K Danoff
Journal:  BMJ       Date:  2016-02-24

2.  Chemokine signaling axis between endothelial and myeloid cells regulates development of pulmonary hypertension associated with pulmonary fibrosis and hypoxia.

Authors:  Aline C Oliveira; Chunhua Fu; Yuanqing Lu; Mason A Williams; Liya Pi; Mark L Brantly; Corey E Ventetuolo; Mohan K Raizada; Borna Mehrad; Edward W Scott; Andrew J Bryant
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-07-31       Impact factor: 5.464

3.  Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Proposal.

Authors:  Kerri Johannson; Harold R Collard
Journal:  Curr Respir Care Rep       Date:  2013-12

Review 4.  Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies.

Authors:  Maya M Juarez; Andrew L Chan; Andrew G Norris; Brian M Morrissey; Timothy E Albertson
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

Review 5.  New perspectives on management of idiopathic pulmonary fibrosis.

Authors:  Silvia Puglisi; Sebastiano Emanuele Torrisi; Virginia Vindigni; Riccardo Giuliano; Stefano Palmucci; Massimiliano Mulè; Carlo Vancheri
Journal:  Ther Adv Chronic Dis       Date:  2016-02-01       Impact factor: 5.091

6.  Relationship between quantitative CT metrics and pulmonary function in combined pulmonary fibrosis and emphysema.

Authors:  Katsutoshi Ando; Mitsuaki Sekiya; Kazunori Tobino; Kazuhisa Takahashi
Journal:  Lung       Date:  2013-10-02       Impact factor: 2.584

7.  A systematic review of the incidence, risk factors and prognosis of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease.

Authors:  Hiroyuki Kamiya; Ogee Mer Panlaqui
Journal:  BMC Pulm Med       Date:  2021-05-05       Impact factor: 3.317

8.  Approach to acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Hammad Bhatti; Ankur Girdhar; Faisal Usman; James Cury; Abubakr Bajwa
Journal:  Ann Thorac Med       Date:  2013-04       Impact factor: 2.219

9.  Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges.

Authors:  Paolo Spagnolo; Roberto Tonelli; Elisabetta Cocconcelli; Alessandro Stefani; Luca Richeldi
Journal:  Multidiscip Respir Med       Date:  2012-11-12

Review 10.  Acute exacerbation of interstitial lung disease associated with rheumatic disease.

Authors:  Fabrizio Luppi; Marco Sebastiani; Carlo Salvarani; Elisabeth Bendstrup; Andreina Manfredi
Journal:  Nat Rev Rheumatol       Date:  2021-12-07       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.